Company Tagline
Seeking to improve lives through the curative potential of gene therapy.
Industry Category
Business Keywords
Company Description
REGENXBIO is a leading biotechnology company dedicated to improving lives through the innovative application of gene therapy. Focused on the development of AAV Therapeutics, REGENXBIO is pioneering a new class of gene therapy medicines with the potential to transform healthcare for millions. With a commitment to innovation and patient well-being, REGENXBIO continues to advance cutting-edge research and development initiatives.
REGENXBIO is actively advancing a robust pipeline of AAV Therapeutics targeting retinal and rare diseases. This includes ABBV-RGX-314, in collaboration with AbbVie, for the treatment of wet AMD and diabetic retinopathy, RGX-202 for Duchenne, and RGX-121 for MPS II. With a focus on one-time treatments, REGENXBIO is committed to making a significant impact on patient outcomes. The primary address of REGENXBIO is 9804 Medical Center Dr, Rockville, Maryland 20850, US.
REGENXBIO's dedication to advancing gene therapy has already impacted thousands of patients through its AAV Therapeutic platform, including its use in Novartis’ ZOLGENSMA for spinal muscular atrophy. As REGENXBIO continues to push the boundaries of biotechnology, it remains steadfast in its mission to deliver curative potential to those in need. We invite the manager of REGENXBIO to create a customized and exclusive company showcase and product listing on our platform to further amplify REGENXBIO’s reach and impact.
REGENXBIO est une société de biotechnologie de premier plan dédiée à l'amélioration des vies grâce à l'application innovante de la thérapie génique. Axée sur le développement des thérapeutiques AAV, REGENXBIO est pionnière dans une nouvelle classe de médicaments de thérapie génique ayant le potentiel de transformer les soins de santé pour des millions de personnes. Avec un engagement envers l'innovation et le bien-être des patients, REGENXBIO continue de faire progresser la recherche et le développement de pointe.
REGENXBIO fait progresser activement un solide pipeline de thérapeutiques AAV ciblant les maladies rétiniennes et rares. Cela comprend ABBV-RGX-314, en collaboration avec AbbVie, pour le traitement de la DMLA humide et de la rétinopathie diabétique, RGX-202 pour Duchenne et RGX-121 pour la MPS II. En mettant l'accent sur les traitements uniques, REGENXBIO s'engage à avoir un impact significatif sur les résultats pour les patients. L'adresse principale de REGENXBIO est 9804 Medical Center Dr, Rockville, Maryland 20850, US.
Le dévouement de REGENXBIO à faire progresser la thérapie génique a déjà eu un impact sur des milliers de patients grâce à sa plateforme thérapeutique AAV, y compris son utilisation dans ZOLGENSMA de Novartis pour l'amyotrophie spinale. Alors que REGENXBIO continue de repousser les limites de la biotechnologie, elle reste ferme dans sa mission d'offrir un potentiel curatif à ceux qui en ont besoin. Nous invitons le responsable de REGENXBIO à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'amplifier davantage la portée et l'impact de REGENXBIO.
Key Personnel / Employees
Compare Companies Side by Side
Compare REGENXBIO with 3 companies in Biotechnology-Research
| Comparison Field |
REGENXBIOMain Company |
LonzaView Profile |
Capsida Biotherapeut...View Profile |
GEEN Biotechnology,...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1897 | 2019 | 2015 |
|
Company Size
|
— | 10,001+ | 51-200 | 2-10 |
|
City
|
Rockville, Maryland | Newbury Park, CA | Istanbul, Esenler | |
|
Country
|
United States | United States | Turkey | |
|
Skills & Keywords
Comparing with main company
|
7 Total Skills
Gene Therapy
AAV Therapeutics
Biotechnology
Retinal Diseases
Rare Diseases
Biopharmaceuticals
Clinical-Stage Biotechnology
|
7 Total
7 Unique
Unique Skills:
Bioscience
Capsules
Cell Therapy
Custom manufacturing
Life science ingredients
Nutrition
+1
|
5 Total
5 Unique
Unique Skills:
AAV Engineering
AAV Immunology
Analytical Development
Process Development
Protein Engineering
|
7 Total
7 Unique
Unique Skills:
Genetic Engineering
Genetically Modified Organisms (GMO)
Industrial Cell Development
Master Cell Banking
Metabolism Engineering
Recombinant DNA Technology
+1
|
4
Total Companies1897
Oldest Founded2
Countries26
Unique SkillsSimilar Companies
Other organizations in the same industry
TFChem
Biotechnology-ResearchDevelop innovative actives for tomorrow’s Drugs and Cosmetics
Ascension Sciences
Biotechnology-ResearchNano Solutions, Macro Possibilities | Advanced nanoparticle formulation for nutraceuticals and pharm...
Tisento Therapeutics
Biotechnology-ResearchTo those lacking effective treatment options: We hear you. And we are relentlessly driving toward mu...
Confidence Analytics®
Biotechnology-ResearchCannabis. Certified.
Alternative Company Names
This company is also known as